NICE Publishes Draft Guidance Recommending the Endosure Test.
Mark Noar • July 7, 2026

The NICE published draft guidance recommending the EndoSure test diagnostic technology. The test will be used in the NHS to speed up endometriosis diagnosis at the primary care level.

Endometriosis actually affects one in four women of reproductive age. Endometriosis currently takes an average of more than nine years to diagnose in the UK. This new non-invasive test offers primary care professionals a better tool to identify the condition earlier, without relying on specialist ultrasound expertise.

The EndoSure test will be paid for all women in the NHS during a three-year evidence generation period, with NICE reviewing progress annually.

Women's health is a priority for NICE. This draft guidance builds on the updated endometriosis guideline (NG73), fertility guideline (NG257), and two recently recommended hormonal treatments for endometriosis symptoms.

Learn more about the NICE recommendations: https://lnkd.in/d5hnS8iu


EndoSure CE Marking for commercial use in the EU

ENDOSURE TEST RECEIVES CE MARKING FOR THE EUROPEAN UNION

By Mark Noar • April 15, 2026
EndoSure announces that its ENDOSURE TEST has received CE Marking for commercial use in the European Union. This is a huge milestone to help women.
Woman taking ENDOSURE TEST for endometriosis diagnosis

ENDOSURE, INC. Announces Development of @Home Version of Award Winning ENDOSURE TEST

By Leah Hird • March 17, 2026
ENDOSURE, INC. announces development of @HOME TEST version of ENDOSURE TEST. Once released, it will make endometriosis testing possible at home.